New therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis

Details for Australian Patent Application No. 2009242126 (hide)

Owner Pharnext

Inventors Graudens, Esther; Guerassimenko, Oxana; Nabirochkin, Serguei; Chumakov, Ilya; Cohen, Daniel

Agent Davies Collison Cave

Pub. Number AU-A-2009242126

PCT Pub. Number WO2009/133141

Priority 61/048,583 29.04.08 US

Filing date 29 April 2009

Wipo publication date 5 November 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/133141 Priority application(s): WO2009/133141

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009242127-New therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of cell stress response

2009242122-Pegylated recombinant human growth hormone compounds